期刊文献+

一组可提供AAV载体复制和包装功能的重组HSV-1 被引量:5

Generation of a series of recombinant herpes simplex viruses which can provide replicating and packaging functions for recombinant adeno-associated virus
原文传递
导出
摘要 目的 构建一组具有AAV载体复制和包装功能的重组HSV 1,从中选出功能较强者用于重组AAV的生产。方法 采用一套含有HSV 1基因组的粘粒系统构建重组HSV 1。首先将 2型腺病毒伴随病毒 (AAV 2 )rep基因的起始密码子ATG人工定点突变成ACG ;然后将自身启动子控制下的AAV 2rep(起始密码子突变或未突变 )和cap基因分别插入粘粒上HSV 1的UL2基因或UL44基因 ,构建成重组粘粒cos6 rmc ΔUL2、cos5 6 rc ΔUL44cos5 6 rmc ΔUL44 ;将重组粘粒上的HSV 1片段分别与HSV 1的其余片段进行同源重组 ,得到 3株重组HSV 1。连同过去报道的一株重组HSV 1一起 ,分别命名为HSV1 rc ΔUL2、HSV1 rmc ΔUL2、HSV1 rc ΔUL44、HSV1 rmc ΔUL44。结果  4株重组HSV 1经PCR鉴定均含有rep基因 ,分别感染携带绿色荧光蛋白 (GFP)基因的AAV载体细胞株后均能产生重组AAV。重组AAV可在BHK 2 1细胞中表达GFP。HSV1 rc ΔUL2和HSV1 rmc ΔUL2对AAV载体的包装能力明显强于HSV1 rc ΔUL44和HSV1 rmc ΔUL44。结论 构建的 4株重组HSV 1均具有复制和包装重组AAV的能力。其中HSV1 rc ΔUL2和HSV1 rmc ΔUL2功能较强 。 Objective To construct a series of recombinant herpes simplex viruses that can provide replicating and packaging functions for recombinant adeno-associated virus (rAAV), and to select the strains possessing stronger functions for large-scale production of rAAV.Methods A set of cosmids that represents the whole genome of HSV-1 was used to generate recombinant HSV-1 expressing %rep% and %cap% proteins of AAV-2. An ATG-to-ACG mutation in the start codon of AAV-2 %rep% protein was generated by site-directed mutagenesis. %rep% and %cap% genes, under control of their native promoters, with or without the ATG-to-ACG mutation in the start codon of %rep%, were inserted into the Xba Ⅰ site of UL2 or UL44 genes, respectively, resulting in the recombinant cosmids cos6-rmc/ΔUL2, cos56-rc/ΔUL44 and cos56-rmc/ΔUL44. Homologous recombination among the HSV-1 fragment on the recombinant cosmids and the rest fragments of HSV-1genome resulted in three strains of recombinant HSV-1. Together with the one was constructed previously, there were four strains of recombinant HSV-1 named HSV1-rc/ΔUL2,HSV1-rmc/ΔUL2,HSV1-rc/ΔUL44 and HSV1-rmc/ΔUL44 respectively. Results PCR detection confirmed the existence of rep gene in the genomes of all four strains of the recombinant HSV-1. Recombinant AAV was produced after infecting the AAV vector cell line that carrying the GFP expression cassette with the four strains of recombinant HSV-1 respectively. However, HSV1-rc/ΔUL2 and HSV1-rmc/ΔUL2 produced much more rAAV than HSV1-rc/ΔUL44 and HSV1-rmc/ΔUL44 did. Conclusion All the four strains of recombinant HSV-1 support rAAV replication and packaging. HSV1-rc/ΔUL2 and HSV1-rmc/ΔUL2 that provide much stronger functions may be useful for large-scale production of rAAV.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2002年第1期74-76,共3页 Chinese Journal of Experimental and Clinical Virology
基金 国家"八六三"高科技发展计划基因治疗重大关键技术资助项目 ( 86 3 BH0 3 0 5 0 2 ) 国家攀登计划资助项目
关键词 遗传重组 腺病毒科 人疱疹病毒 AAV载体复制 包装功能 Recombination, genetie Adenoviridae Herpesvirus hominis
  • 相关文献

参考文献3

二级参考文献9

共引文献43

同被引文献34

  • 1王传玺,韩金祥,鲁艳芹,高雪芹,张翠.肝细胞靶向性系统表达载体的构建[J].生物技术通讯,2004,15(5):429-432. 被引量:3
  • 2彭建强,彭忞,谭淑萍,曹晖,连忠辉,董小岩,吴小兵.一种高效快速浓缩腺相关病毒载体的方法[J].病毒学报,2005,21(1):11-14. 被引量:3
  • 3王丽,王素霞,梅长林.RNA干扰对比观察HIF1α和HIF2α在人肾癌细胞中的作用及机制[J].第二军医大学学报,2006,27(6):590-593. 被引量:5
  • 4孙学军,彭兆云,陈箫莹,陶恒沂.活性氧对低氧诱导因子的调节[J].第二军医大学学报,2006,27(6):660-664. 被引量:7
  • 5Yoshihara T, Takiguchi S, Kyuno A, et al. Immunoreactivity of phage library-derived human single-chain antibodies to amyloid beta conformers In vitro[J]. J Biochem, 2008, 143(4) : 475 -486.
  • 6Pride M, Seubert P, Grundman M, et al. Progress in the active immunotherapeutic approach to Alzheimer's disease: clinical investigations into AN1792-associated meningoencephalitis[ J]. Neurodegener Dis, 2008, 5(3 -4) : 194 - 196.
  • 7Steinitz M. Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease [ J ]. Expert Opin Biol Ther, 2008, 8(5) : 633 -642.
  • 8Racke MM, Boone LI, Hepburn DL, et al. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta[ J]. J Neurosci, 2005, 25 (3) : 629 - 636.
  • 9Pfeifer M, Boncristiano S, Bondolfi L, et al. Cerebral hemorrhage after passive anti-Abeta immunotherapy [ J ]. Science, 2002, 298 (5597) : 1379.
  • 10Wilcock DM, Rojiani A, Rosenthal A, et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage[J]. J Neuroinfiamm, 2004, 1(1): 24-35.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部